top of page

Shulman M, Meyers-Ohki S, Novo P, Provost S, Ohrtman K, Van Veldhuisen P, Oden N, Otterstatter M, Bailey GL, Liu D, Rotrosen J, Weiss RD, Nunes EV. Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD). Contemporary Clinical Trials, Volume 150, 2025, 107816, ISSN 1551-7144. https://doi.org/10.1016/j.cct.2025.107816.

Bailey AJ, Votaw VR, Weiss RD, McHugh RK. Capturing the Full-Range of Buprenorphine Treatment Response. JAMA Psychiatry, 2024 Dec 4. doi: 10.1001/jamapsychiatry.2024.3836. Online ahead of print.PMID: 39630467

Weinstein ZM, Yu O, Wartko PD, Samet JH, Bobb JF, Braciszewski JM, Arnsten JH, Murphy MT, Horigian VE, Stotts AL, Beers D, Bradley K. Does implementation of office based addiction treatment by a nurse care manager increase the duration of OUD treatment in primary care? A secondary analysis of the PROUD randomized control trial. Drug and Alcohol Dependence, Volume 265, 2024, 112497. ISSN 0376-8716, https://doi.org/10.1016/j.drugalcdep.2024.112497.

Lu T, Ryan D, Cadet T, Chawarski MC, Coupet E Jr, Edelman EJ, Hawk KF, Huntley K, Jalali A, O'Connor PG, Owens PH, Martel SH, Fiellin DA, D'Onofrio G, Murphy SM. Cost-Effectiveness of Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder. Ann Emerg Med. 2024 Nov 20:S0196-0644(24)01116-8. doi: 10.1016/j.annemergmed.2024.10.001. Online ahead of print. PMID: 39570250

Justen M, Edelman EJ, Chawarski M, Coupet E, Cowan E, Lyonsf M, Owens P, Martel S, Richardson L, Rothman R, Whiteside L, O'Connor P, Zahni E, D'Onofrio G, Fiellin D, Hawk K. Perspectives on and experiences of emergency department–initiated buprenorphine among clinical pharmacists: A multi-site qualitative study. Journal of Substance Use & Addiction Treatment, Volume 155, 209058

Recent Publications

Protocol publications (select each protocol)

Emergency Department-INitiated bupreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION)

Sub Study: Emergency Department-INitiated bupreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION)

bottom of page